The Competition Commission of India ( CCI ) on Tuesday approved the proposed acquisition of Bharat Serums and Vaccines by Mankind Pharma for Rs 13,630 crore. Listed firm Mankind Pharma is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical finished dosage formulations. "Commission approves acquisition of Bharat Serums and Vaccines Limited by Mankid Pharma Ltd," the regulator said in a post on X.
Mankind, through its subsidiaries also, involved in the manufacturing and sale of active pharmaceutical ingredients (APIs), pharmaceutical intermediaries, and packaging products for pharmaceutical products. Bharat Serums and Vaccines Ltd (BSV) is engaged in research, development, licensing, manufacturing, importing, exporting, marketing and distribution of pharmaceutical formulations/ FDFs, APIs, food and health supplements. BSV is also a biopharmaceutical leader in women's healthcare , assisted reproductive treatment, critical care and emergency medicine.
Artificial Intelligence(AI) Java Programming with ChatGPT: Learn using Generative AI By - Metla Sudha Sekhar, Developer and Lead Instructor View Program Artificial Intelligence(AI) Basics of Generative AI : Unveiling Tomorrow's Innovations By - Metla Sudha Sekhar, Developer and Lead Instructor View Program Artificial Intelligence(AI) Generative AI for Dynamic Java Web Applications with ChatGPT By - Metla Sudha Sekhar, Developer and Lead Instructor View Program Artificial Intelligence(AI) Mastering C.
